The Predictive Value of Mitochondrial Fusion Protein 2 in Ovarian Cancer Tissue for Recurrence After Initial Tumor Cell Reduction Surgery

JIA Yingna, ZHENG Cui, HE Hui, XU Jinghua

PDF(1795 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1795 KB)
Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (10) : 1907-1912. DOI: 10.11748/bjmy.issn.1006-1703.2024.10.027
Clinical Investigation

The Predictive Value of Mitochondrial Fusion Protein 2 in Ovarian Cancer Tissue for Recurrence After Initial Tumor Cell Reduction Surgery

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(10): 1907-1912 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.10.027

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1795 KB)

Accesses

Citation

Detail

Sections
Recommended

/